163 related articles for article (PubMed ID: 8367528)
1. Liposomal delivery of a photosensitizer, benzoporphyrin derivative monoacid ring A (BPD), to tumor tissue in a mouse tumor model.
Richter AM; Waterfield E; Jain AK; Canaan AJ; Allison BA; Levy JG
Photochem Photobiol; 1993 Jun; 57(6):1000-6. PubMed ID: 8367528
[TBL] [Abstract][Full Text] [Related]
2. Photosensitising potency of structural analogues of benzoporphyrin derivative (BPD) in a mouse tumour model.
Richter AM; Waterfield E; Jain AK; Allison B; Sternberg ED; Dolphin D; Levy JG
Br J Cancer; 1991 Jan; 63(1):87-93. PubMed ID: 1989669
[TBL] [Abstract][Full Text] [Related]
3. Biodistribution of tritiated benzoporphyrin derivative (3H-BPD-MA), a new potent photosensitizer, in normal and tumor-bearing mice.
Richter AM; Cerruti-Sola S; Sternberg ED; Dolphin D; Levy JG
J Photochem Photobiol B; 1990 Apr; 5(2):231-44. PubMed ID: 2111398
[TBL] [Abstract][Full Text] [Related]
4. Biodistribution of a benzoporphyrin derivative-monoclonal antibody conjugate in A549-tumor-bearing nude mice.
Jiang FN; Richter AM; Jain AK; Levy JG; Smits C
Biotechnol Ther; 1993; 4(1-2):43-61. PubMed ID: 8374512
[TBL] [Abstract][Full Text] [Related]
5. Antiangiogenic photodynamic therapy (PDT) using Visudyne causes effective suppression of tumor growth.
Ichikawa K; Takeuchi Y; Yonezawa S; Hikita T; Kurohane K; Namba Y; Oku N
Cancer Lett; 2004 Mar; 205(1):39-48. PubMed ID: 15036659
[TBL] [Abstract][Full Text] [Related]
6. Modified polyvinyl alcohol-benzoporphyrin derivative conjugates as phototoxic agents.
Davis N; Liu D; Jain AK; Jiang SY; Jiang F; Richter A; Levy JG
Photochem Photobiol; 1993 Apr; 57(4):641-7. PubMed ID: 8506392
[TBL] [Abstract][Full Text] [Related]
7. Photodynamic therapy targeted to tumor-induced angiogenic vessels.
Kurohane K; Tominaga A; Sato K; North JR; Namba Y; Oku N
Cancer Lett; 2001 Jun; 167(1):49-56. PubMed ID: 11323098
[TBL] [Abstract][Full Text] [Related]
8. Photosensitizing efficiency of two regioisomers of the benzoporphyrin derivative monoacid ring A (BPD-MA).
Richter AM; Jain AK; Canaan AJ; Waterfield E; Sternberg ED; Levy JG
Biochem Pharmacol; 1992 Jun; 43(11):2349-58. PubMed ID: 1610400
[TBL] [Abstract][Full Text] [Related]
9. Accumulation of benzoporphyrin derivative in malignant and host cell populations of the murine RIF tumor.
Korbelik M; Krosl G
Cancer Lett; 1995 Nov; 97(2):249-54. PubMed ID: 7497470
[TBL] [Abstract][Full Text] [Related]
10. Photodynamic therapy of experimental choroidal melanoma using lipoprotein-delivered benzoporphyrin.
Schmidt-Erfurth U; Bauman W; Gragoudas E; Flotte TJ; Michaud NA; Birngruber R; Hasan T
Ophthalmology; 1994 Jan; 101(1):89-99. PubMed ID: 8302569
[TBL] [Abstract][Full Text] [Related]
11. PEGylation of liposome decreases the susceptibility of liposomal drug in cancer photodynamic therapy.
Ichikawa K; Hikita T; Maeda N; Takeuchi Y; Namba Y; Oku N
Biol Pharm Bull; 2004 Mar; 27(3):443-4. PubMed ID: 14993821
[TBL] [Abstract][Full Text] [Related]
12. Induction of intensive tumor suppression by antiangiogenic photodynamic therapy using polycation-modified liposomal photosensitizer.
Takeuchi Y; Kurohane K; Ichikawa K; Yonezawa S; Nango M; Oku N
Cancer; 2003 Apr; 97(8):2027-34. PubMed ID: 12673734
[TBL] [Abstract][Full Text] [Related]
13. The plasma distribution of benzoporphyrin derivative and the effects of plasma lipoproteins on its biodistribution.
Allison BA; Pritchard PH; Richter AM; Levy JG
Photochem Photobiol; 1990 Sep; 52(3):501-7. PubMed ID: 2284344
[TBL] [Abstract][Full Text] [Related]
14. Antiangiogenic photodynamic therapy with targeted liposomes.
Oku N; Ishii T
Methods Enzymol; 2009; 465():313-30. PubMed ID: 19913174
[TBL] [Abstract][Full Text] [Related]
15. Localization of lipoprotein-delivered benzoporphyrin derivative in the rabbit eye.
Haimovici R; Kramer M; Miller JW; Hasan T; Flotte TJ; Schomacker KT; Gragoudas ES
Curr Eye Res; 1997 Feb; 16(2):83-90. PubMed ID: 9068937
[TBL] [Abstract][Full Text] [Related]
16. Uptake of verteporfin by articular tissues following systemic and intra-articular administration.
Chowdhary RK; Ratkay LG; Canaan AJ; Waterfield JD; Richter AM; Levy JG
Biopharm Drug Dispos; 1998 Sep; 19(6):395-400. PubMed ID: 9737820
[TBL] [Abstract][Full Text] [Related]
17. Antiangiogenic photodynamic therapy (PDT) by using long-circulating liposomes modified with peptide specific to angiogenic vessels.
Ichikawa K; Hikita T; Maeda N; Yonezawa S; Takeuchi Y; Asai T; Namba Y; Oku N
Biochim Biophys Acta; 2005 May; 1669(1):69-74. PubMed ID: 15843001
[TBL] [Abstract][Full Text] [Related]
18. Skin necrosis due to photodynamic action of benzoporphyrin depends on circulating rather than tissue drug levels: implications for control of photodynamic therapy.
Lin GC; Tsoukas ML; Lee MS; González S; Vibhagool C; Anderson RR; Kollias N
Photochem Photobiol; 1998 Oct; 68(4):575-83. PubMed ID: 9796441
[TBL] [Abstract][Full Text] [Related]
19. The effects of plasma lipoproteins on in vitro tumor cell killing and in vivo tumor photosensitization with benzoporphyrin derivative.
Allison BA; Waterfield E; Richter AM; Levy JG
Photochem Photobiol; 1991 Nov; 54(5):709-15. PubMed ID: 1798748
[TBL] [Abstract][Full Text] [Related]
20. Application of long-circulating liposomes to cancer photodynamic therapy.
Oku N; Saito N; Namba Y; Tsukada H; Dolphin D; Okada S
Biol Pharm Bull; 1997 Jun; 20(6):670-3. PubMed ID: 9212988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
